IL-11 overexpression promotes tumor progression and T cell dysfunction, whereas IL-11 knockdown reverses lactate-induced CD8+ T cell exhaustion, and cholesterol-modified siIL11 restores cytotoxic activity, improving immunotherapy efficacy (42). This evidence concerns the gene CD8A and neoplasm.